Process for the preparation of quinolone based compounds

Patent metadata

Field	Value
Publication number	US-10899713-B2
Application number	US-201916421671-A
Country	US
Kind code	B2
Filing date	May 24, 2019
Priority date	May 25, 2018
Publication date	Jan 26, 2021
Grant date	Jan 26, 2021

Abstract

The present invention relates to an improved process for the preparation of quinolone based compounds of general formula (I) using intermediate compound of general formula (XII). Invention also provides an improved process for the preparation of compound of formula (I-a) using intermediate compound of formula (XII-a) and some novel impurities generated during process. Compounds prepared using this process can be used to treat anemia.

First claim

The invention claimed is:

1. A process for the preparation of compound of formula (I),

wherein A is optionally substituted aryl ring,
R 1 represents hydrogen, optionally substituted (C 1 -C 10 )alkyl, (C 3 -C 8 )cycloalkyl, (C 5 -C 8 )cycloalkenyl, aryl, cycloalkanylalkyl, heteroaralkyl, heterocyclylalkyl groups,
comprising following steps:
Step 1) reacting 2-hydroxyisoindoline-1,3-dione with compound of formula (VII) in presence of appropreate base, solvents and reagents to get compound of formula (VIII) which is further converted to compound of formula (X) after protection with Boc-anhydride;

Step 2) reacting compound of formula (X) with compound of formula (XI) with suitable reagent in presence of suitable base and solvent at 78-85° C. temperature range to give compound (XII);

Step 3) deprotecting the compound of formula (XII) in presence of suitable reagents to give compound (XIII);

Step 4) reacting compound of formula (XIII) with ethyl hydrogen malonate to give compound of formula (XIV);

Step 5) reacting compound of formula (XIV) further with suitable reagents such as sodium methoxide and sodium ethoxide and suitable solvents such as methanol, ethanol, dimethyl formamide and DMSO to give compound of formula (XV);

Step 6) reacting compound of formula (XV) with HCl salt of Glycine ethyl ester to give compound of formula (XVI);

Step 7) reacting compound of formula (XVI) with suitable acid to form compound for formula (I);

2. The process according to claim 1 in step 1, wherein appropriate base is selected from sodium carbonate, Potassium carbonate, sodium hydride, potassium hydroxide, sodium hydroxide, triethyl amine, N,N-diisoppropyl ethyl amine, DBU, DBN and DABCO.

3. The process according to claim 1 in step 1, wherein appropriate solvent is selected from dimethyl sulfoxide, dimethyl formamide, tetrahydrofuran, dichloromethane, ethanol, methanol, toluene, ethyl acetate and acetonitrile.

4. The process according to claim 1 in step 1, wherein appropriate reagents are selected from hydrazine hydrate, methyl hydrazine, ammonia (for part B), Boc.-anhydride (for part C) and imidazole (for part D).

5. The process according to claim 1 in step 2, wherein reagents are copper iodide and glycine.

6. The process according to claim 1 in step 2, wherein base is selected from caesium carbonate, potassium carbonate, sodium tert-butoxide and potassium phosphate tribasic.

7. The process according to claim 1 in step 2, wherein solvent is selected from toluene, dimethyl formamide, 1,4-dioxane, dimethoxyethane, ethanol, methanol, isopropyl alcohol, butanol and mixture of solvent.

8. The process according to claim 1 in step 3, wherein reagent used for deprotection is selected from methanolic HCl, isopropyl HCl, ethanolic HCl and alcoholic solution of p-toluene sulphonic acid.

9. The process according to claim 1 in step 4, wherein reagent is phosphorous oxychloride.

10. The process according to claim 1 in step 4, wherein base is selected from triethyl amine, pyridine and N, N-diisopropyl ethyl amine.

11. The process according to claim 1 in step 4, wherein solvent is selected from dichloromethane, acetonitrile and toluene.

12. The process according to claim 1 in step 5, wherein reagent is selected from sodium methoxide and sodium ethoxide.

13. The process according to claim 1 in step 5, wherein acid for neutralization is selected from aq. Hydrochloric acid, citric acid, acetic acid and sulphuric acid.

14. The process according to claim 1 in step 5, wherein solvent is selected from methanol, ethanol, dimethyl formamide and DMSO.

15. The process according to claim 1 in step 6, wherein base is selected from N, N-diisopropylethyl amine and triethyl amine.

16. The process according to claim 1 in step 6, wherein solvent is selected from 1,4-dioxane, acetonitrile, tetrahydrofuran, ethyl acetate, toluene, methanol and ethanol.

17. The process according to claim 1 in step 7, wherein base is selected from sodium hydroxide, lithium hydroxide, potassium hydroxide.

18. The process according to claim 1 in step 7, wherein acid for acidification is selected from hydrochloric acid, citric acid, sulphuric acid and acetic acid.

19. A process for the preparation of compound of formula (I-a),

comprising following steps:
Step 1a) reacting 2-hydroxyisoindoline-1,3-dione with (bromomethyl)cyclopropane VII-a) in presence of appropreate base, solvents and reagents to get 2-(cyclopropylmethoxy)isoindoline-1,3-dione (VIII-a) which is further converted to tert-butyl (cyclopropylmethoxy)carbamate (X-a) after protection with Boc-anhydride

Step 2a) reacting tert-butyl (cyclopropylmethoxy)carbamate (X-a) with ethyl 2-iodobenzoate (XI-a) with suitable reagent in presence of suitable base and solvent at 78-85° C. temperature range to give compound (XII-a)

Step 3a) Deprotecting the compound ethyl 2-((tert-butoxycarbonyl)(cyclopropylmethoxy)amino)benzoate (XII-a) in presence of suitable reagents such as alcoholic solution of acid to give ethyl 2-((cyclopropylmethoxy)amino)benzoate (XIII-a)

Step 4a) reacting ethyl 2-((cyclopropylmethoxy)amino)benzoate (XIII-a) with ethyl hydrogen malonate to give ethyl 2-(N-(cyclopropylmethoxy)-3-ethoxy-3-oxopropanamido)benzoate (XIV-a)

Step 5a) reacting ethyl 2-(N-(cyclopropylmethoxy)-3-ethoxy-3-oxopropanamido)benzoate (XIV-a) further with suitable reagents sodium methoxide and sodium ethoxide and solvents to give ethyl 1-(cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate (XV-a)

Step 6a) reacting ethyl 1-(cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate (XV-a) with HCl salt of Glycine ethyl ester to give ethyl (1-(cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)glycinate (XVI-a)

Step 7a) hydrolyzing ethyl (1-(cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)glycinate (XVI-a) with suitable acid

Assignees

• Cadila Healthcare Ltd

Inventors

• Desai Ranjit C
• Sharma Rajiv
• Pandya Vrajesh
• Shah Kalpesh
• Patel Sunil
• Chauhan Rakesh
• Nair Ranjeet
• Joshi Vivek
• Patel Manoj
• Shukla Mrigendra

Classifications

• C07D215/58 Primary

  with hetero atoms directly attached to the ring nitrogen atom · CPC title

• C07C239/20

  having oxygen atoms of hydroxylamino groups etherified · CPC title

• C07C2601/02

  with a three-membered ring · CPC title

• C07D215/56 Primary

  with oxygen atoms in position 4 · CPC title

• C07C291/02

  containing nitrogen-oxide bonds · CPC title